Diethylaminoethyl methacrylate methyl methacrylate | 138164-48-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Diethylaminoethyl methacrylate methyl methacrylate
• 英文别名: 2-(diethylamino)ethyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate
• CAS: 138164-48-4
• 化学式: C15H27NO4
• 分子量: 285.38
• InChiKey: UIMGFUHIJYYYPC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.18
• 重原子数：
  20
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  N,N-diethyl-O-methacryloylhydroxylamine 、 甲基丙烯酸甲酯 、 2-[(1-amino-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidamide;hydron;dichloride 、 在 氮 、 水 作用下， 以 水 为溶剂， 反应 24.0h， 生成 Diethylaminoethyl methacrylate methyl methacrylate
  参考文献：
  名称：

  Microcapsule and microcapsule toner

  摘要：

  一种微胶囊和一种微胶囊调色剂，每种包括一个核心材料和一个外壳，其中外壳包含一种乙烯基聚合物和一种聚合物，该聚合物包括至少两种可共聚的单体，位于核心材料表面上，并且一种制备微胶囊的方法，包括以下步骤：在水性介质中乳化亲脂性核心材料，并使至少两种可共聚的单体在乙烯基聚合物存在下共聚，位于所得乳液中核心材料的油滴表面上形成外壳。

  公开号：

  US05484677A1

文献信息

• Improved blood-purifying membrane and process for preparation thereof
  申请人：Asahi Kasei Kogyo Kabushiki Kaisha

  公开号：EP0232442A1

  公开（公告）日：1987-08-19

  Disclosed is a blood-purifying regenerated cellulose membrane composed of regenerated cellulose, a blood-con­tacting surface of said membrane being coated with a polymeric substance. The polymeric substance is a homopolymer or copolymer of a basic vinyl monomer having an amino group in the side chain. The membrane is characterized in that the occurrence of the leukopenia phenomenon and the activation of the complement system are mitigated and such improved properties can last for a long period.

  本发明公开了一种血液净化再生纤维素膜，该膜由再生纤维素组成，其与血液接触的表面涂有聚合物质。聚合物质是侧链中含有氨基的基本乙烯基单体的均聚物或共聚物。这种膜的特点是可减轻白细胞减少现象的发生和补体系统的激活，而且这种改进的特性可持续很长时间。
• COMPRESSION-MOLDED PREPARATION
  申请人：Nippon Shinyaku Co., Ltd.

  公开号：EP3398588A1

  公开（公告）日：2018-11-07

  An object of the present invention is to provide a compression-molded preparation which has an excellent disintegration property and can be easily produced despite the use of granules coated with a polymer coating film having a function such as masking of an unpleasant taste. A compression-molded preparation achieving the above object is characterized by including granules obtained by coating a polymer-coated, granulated substance, in which a granulated substance containing a drug is coated with a polymer coating film, with one kind or two or more kinds of additives selected from the group consisting of a metal stearate, stearic acid, a sucrose fatty acid ester, talc, and silicic acid.

  本发明的目的是提供一种压缩成型制剂，它具有极佳的崩解性能，尽管使用了涂有具有掩盖异味等功能的聚合物包衣膜的颗粒，但仍可轻松生产。实现上述目的的压缩模塑制剂的特征是包括通过涂覆聚合物包衣颗粒物质而获得的颗粒，其中含有药物的颗粒物质涂覆有聚合物包衣膜，并添加了一种或两种或两种以上的添加剂，这些添加剂选自金属硬脂酸盐、硬脂酸、蔗糖脂肪酸酯、滑石粉和硅酸组成的组。
• MICRODRESSINGS FOR SKIN TREATMENT
  申请人：Cytrellis Biosystems, Inc.

  公开号：EP3456300A1

  公开（公告）日：2019-03-20

  The present invention relates to microclosures and methods for treating microwounds in the skin (e.g., after incising or excising tissue portions from a subject). Exemplary microclosures include a material having at least one dimension of from about 10 um to about 1 mm after application to a microwound. The microclosure maintains a first compressive force when applied to the microwound.

  本发明涉及用于治疗皮肤微小伤口（例如，在从受试者身上切开或切除组织部分后）的微容器和方法。示例性微封闭体包括一种材料，该材料在应用到微伤口后至少有一个尺寸为约10微米到约1毫米。当施加到微伤口上时，微外壳保持第一压缩力。
• Methods and devices for skin tightening
  申请人：Cytrellis Biosystems, Inc.

  公开号：US10251792B2

  公开（公告）日：2019-04-09

  The present invention relates to methods and devices for skin tightening after incising or excising tissue portions from a subject. Exemplary methods and devices include tunable dressings having an adhesive layer and a regulatable layer or an un-stretched layer that responds to one or more external stimuli to contract or expand the dressing, where the contraction or expansion can be uniform or non-uniform.

  本发明涉及从受试者身上切开或切除组织部分后紧致皮肤的方法和装置。示例性方法和装置包括可调敷料，该敷料具有粘合层和可调节层或未拉伸层，可对一种或多种外部刺激做出反应，使敷料收缩或膨胀，收缩或膨胀可以是均匀的，也可以是非均匀的。
• Production of pharmaceutical protective coatings with good resistance in a neutral environment
  申请人：BASF SE

  公开号：US10912835B2

  公开（公告）日：2021-02-09

  Pharmaceutical coatings obtained from coating compositions based on film-forming copolymers of N,N-diethylaminoethyl methacrylate (DEAEMA) and methyl methacrylate (MMA) comprising a weight ratio of DEAEMA:MMA in the range of 35:65 to 55:45, where the copolymers are present partially neutralized with C3-C10-dicarboxylic acids.

  以甲基丙烯酸 N,N-二乙氨基乙酯（DEAEMA）和甲基丙烯酸甲酯（MMA）的成膜共聚物为基础的涂料组合物制成的药用涂料，其中 DEAEMA 与 MMA 的重量比为 35:65 至 55:45，共聚物与 C3-C10 二羧酸部分中和。